NCT01304784 2015-12-16A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerMerrimack PharmaceuticalsPhase 1 Completed100 enrolled
NCT01097460 2015-01-07MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast CancerMerrimack PharmaceuticalsPhase 1 Completed16 enrolled 7 charts